UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Bamyl500mgtablett-SE-PLC-MPD-BBDL

Bamyl 500 tablett

MPID: SE-100001270-00014792
EURDID: 39

Full name: Bamyl 500 tablett

- Invented name part: Bamyl

- Strength part: 500 mg

- Pharmaceutical dose form part: tablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Tablet

Legal status of supply: Medicinal product subject to medical prescription exempt for some pack sizes

Domain: Human use

Resource status: Current

Product classification:

  • 100000097266 acetylsalicylic acid

Marketing Authorisation 1 of 1

Authorisation number: 14792

Region: Kingdom of Sweden

Marketing authorisation holder: Meda AB

Identifier:

  • LOC-100001591

Status: Valid (2000-12-29)

Package 1 of 1

PCID:

Description:
Blister, 30 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 30 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 3 Blister (Aluminium) (PolyVinyl Chloride)

Containing: 10 Tablet

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Acetylsalicylic acid

Presentation strength: 500 milligram(s) / 1 Tablet

Reference strength:
Acetylicsalicylic acid 500 milligram(s) / 1 Tablet